Physician profile
Muhammad Arshad
NPI 1467735050
$3,392.74
in general payments reported to CMS, 2019-2025
36 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $70.77 · 2021: $49.53 · 2022: $600 · 2023: $950 · 2024: $463 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,644 · Education: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,643.94 |
| Education | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $786.04 | 2021-2025 | Qulipta, Ubrelvy |
| Ucb, INC. | $487.71 | 2022-2025 | Rystiggo, Briviact |
| Novartis Pharmaceuticals Corporation | $393.98 | 2022-2025 | |
| Eisai INC. | $187.44 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $157.67 | 2022-2025 | Ultomiris |
| Amneal Pharmaceuticals LLC | $131.62 | 2022-2025 | Rytary, Crexont |
| Grifols USA, LLC | $114.55 | 2023-2025 | Gamunex-C, Xembify |
| Nevro Corp. | $98.57 | 2024 | Senza |
| Tanabe Pharma America, INC. | $88.21 | 2022-2023 | |
| Genentech USA, INC. | $79.44 | 2023 | Ocrevus, Enspryng |
| Otsuka America Pharmaceutical, INC. | $74.69 | 2023-2025 | Rexulti, Nuedexta |
| Amgen INC. | $70.61 | 2022 | |
| Pfizer INC. | $69.90 | 2023-2025 | |
| Allergan, INC. | $66.40 | 2020-2022 | |
| Impel Pharmaceuticals INC. | $50.20 | 2023 | Trudhesa |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $43.81 | 2023-2024 | Vercise |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.44 | 2022 | |
| Lilly USA, LLC | $42.24 | 2025 | Amyvid, Kisunla |
| Upsher-Smith Laboratories LLC | $41.75 | 2022-2023 | |
| Livanova USA, INC. | $38.32 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Neurelis, INC. | $30.50 | 2022-2023 | Valtoco |
| Avion Pharmaceuticals | $28.63 | 2022 | |
| Medtronic, INC. | $27.83 | 2025 | Aquamantys(Tm) |
| Itamar Medical INC | $27.65 | 2025 | Watchpatone |
| Argenx US, INC. | $27.06 | 2022 | |
| Melinta Therapeutics, LLC | $21.17 | 2020 | |
| Neurocrine Biosciences, INC. | $19.37 | 2023 | Ongentys, Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $18.21 | 2023 | Gammagard |
| Avanir Pharmaceuticals, INC. | $18.13 | 2022 | |
| Octapharma USA, INC. | $17.43 | 2023 | Panzyga |
| Horizon Therapeutics Plc | $17.28 | 2023 | Uplizna |
| Teva Pharmaceuticals USA, INC. | $17.22 | 2023 | Ajovy |
| Celgene Corporation | $15.43 | 2022 | |
| Sk Life Science, INC. | $14.34 | 2023 | |
| Mdd US Operations, LLC | $13.66 | 2022 | |
| Aucta Pharmaceuticals, INC. | $12.24 | 2024 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Arshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.